Latest updates for Merck
Fresh curated links around Merck are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
- Analyst Report: Merck & Co Inc
- Pharma giant Merck to slash 54 jobs at Rahway headquarters
- Merck is a buy as strong cancer drug pipeline offsets Keytruda patent expiration, Morgan Stanley says
Post angles to try
Fresh articles and ideas
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
Pharma giant Merck to slash 54 jobs at Rahway headquarters
The pharmaceutical company Merck & Co. has notified state officials that it will lay off 54 workers at its Rahway headquarters, according to a September filing with the New Jer...
Merck is a buy as strong cancer drug pipeline offsets Keytruda patent expiration, Morgan Stanley says
Merck, which makes the popular cancer treatment Keytruda, is poised to gain ground as its pipeline drugs get close to coming to market, per Morgan Stanley.
FU MERCK!!
FU MERCK!! Anonymous (not verified) Thu, 07/23/2026 - 15:21 field_thread_url https://cafepharma.com/boards/threads/fu-merck.486959/ boar...
Could Merck & Co., Inc. (MRK) and Gilead Sciences, Inc. (GILD)’s Partnership Create the Next Big Pharma Growth Engin...
Merck: 'Strong Buy' Lipfendra FDA First And Continued Oncology Expansions
Merck KGaA lays off 20 staffers in latest blow to US research team
The Massachusetts research site for Merck KGaA’s North American division, EMD Serono, has decided to hand pink slips to 20 staffers, Fierce has learned.
Merck stages expanded access to monthly HIV PrEP pill ahead of approval
Following in the footsteps of Gilead, Merck has signed voluntary licensing agreements to enable access to its investigational HIV PrEP pill alimatravir ahead of any regulatory subm...
Merck, Moderna report positive Phase 3 melanoma results for Keytruda combination
Rahway-based Merck and Moderna said Aug. 19 that a Phase 3 trial of an investigational mRNA-based cancer therapy used in combination with Keytruda met its primary and key secondary...
<![CDATA[ Eli Lilly to Acquire Merida Biosciences for $2.8 Billion ]]>
PCSK9 Pill - When Will Merck Start The Hiring Process ?
PCSK9 Pill - When Will Merck Start The Hiring Process ? Anonymous (not verified) Mon, 07/20/2026 - 15:19 field_thread_url https://cafepharma.com/boards/thr...
PCSK9 Pill - When Will Merck Start The Hiring Process ?
PCSK9 Pill - When Will Merck Start The Hiring Process ? Anonymous (not verified) Wed, 07/22/2026 - 15:21 field_thread_url https://cafepharma.com/boards/thr...
Merck posts—then pulls—trial plan for PD-1xVEGF and TROP2 ADC combination
After keeping tight-lipped for nearly two years, Merck & Co. briefly dropped the first concrete hint as to where it intends to take its PD-1xVEGF bispecific antibody—before qui...
Merck’s $11B anti-TL1A bet delivers 1 win, 1 loss in midphase inflammatory disease trials
A phase 2 trial of Merck & Co.’s anti-TL1A monoclonal antibody has missed its primary endpoint, closing off one avenue for expansion of an asset acquired in a $10.8 billion tak...
<![CDATA[M&A Roundup: LEO Pharma Acquires Dersimelagon, BioMarin Acquires Alesta, OmniAb Enters collaboration wit...
Merck KGaA institutes in-office requirement for US research team that could lead to 70 layoffs
Merck KGaA’s U.S. research site has instituted a new in-office work requirement that may lead to the imminent departure of as many as 70 staffers.
Eli Lilly inks $2.88B Merida buyout for autoimmune drugs against rogue antibodies
Eli Lilly has struck a deal to acquire Merida Biosciences for up to $2.875 billion, establishing a beachhead in efforts to treat disease through the selective degradation of pathog...
Merck wins FDA approval for oral LDL cholesterol drug
Merck won FDA approval for Lipfendra, the first oral PCSK9 inhibitor for adults with high LDL cholesterol and hypercholesterolemia. The post Merck wins FDA approval for oral LDL ch...
Merck after Keytruda: what the pipeline looks like
Delve into what Merck has planned for the future of its pipeline as Keytruda's patent is getting closer to expiry. The post Merck after Keytruda: what the pipeline looks like appe...
Merck wins first approval of a PCSK9 cholesterol pill
The speedy clearance of Lipfendra is an important milestone for Merck and the result of a controversial voucher program put in place by former FDA commissioner Marty Makary.
<![CDATA[Pharmaceutical Executive Daily: Eli Lilly Enters $2.8 Billion Agreement to Acquire Merida Biosciences]]>
Hoechst-Roussel
Hoechst-Roussel Anonymous (not verified) Thu, 07/16/2026 - 12:16 field_thread_url https://cafepharma.com/boards/threads/hoechst-roussel.12347/...
<![CDATA[Simcere Zaiming Licenses Sim0660 to Roche for $1.53 billion]]>
Turn fresh research into a full content calendar
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.